Diffusion kurtosis imaging detects subclinical white matter abnormalities in Phenylketonuria.


Journal

NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070

Informations de publication

Date de publication:
2021
Historique:
received: 17 07 2020
revised: 02 12 2020
accepted: 29 12 2020
pubmed: 19 1 2021
medline: 29 6 2021
entrez: 18 1 2021
Statut: ppublish

Résumé

Phenylketonuria (PKU) is an autosomal recessive disorder whereby deficiencies in phenylalanine metabolism cause progressive neurological dysfunction. Managing PKU is challenging, with disease monitoring focussed on short-term phenylalanine control rather than measures of neuronal damage. Conventional imaging lacks sensitivity, however diffusion kurtosis imaging (DKI), a new MRI method may reveal subclinical white matter structural changes in PKU. This cohort study involved adults with PKU recruited during routine clinical care. MRI, neurocognitive assessment and historical phenylalanine (Phe) levels were collected. A hypothesis-generating case study comparing diet-compliant and non-compliant siblings confirmed that DKI metrics are sensitive to dietary adherence and prompted a candidate metric (K Both siblings scored outside the range of controls for all DKI-based metrics, with severe changes in the periventricular white matter and a gradient of severity toward the cortex. K DKI reveals regionally-specific, progressive abnormalities of brain diffusion characteristics in PKU, even in the absence of conspicuous clinical signs or abnormalities on conventional MRI. A DKI-based marker derived from these scores (K

Identifiants

pubmed: 33461111
pii: S2213-1582(20)30392-2
doi: 10.1016/j.nicl.2020.102555
pmc: PMC7814191
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102555

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Sarah C Hellewell (SC)

Imaging and Phenotyping Laboratory, Charles Perkins Centre, Faculty of Medicine and Health, University of Sydney, NSW, 2006, Australia.

Thomas Welton (T)

Imaging and Phenotyping Laboratory, Charles Perkins Centre, Faculty of Medicine and Health, University of Sydney, NSW, 2006, Australia.

Kate Eisenhuth (K)

Department of Genetic Medicine, Westmead Hospital, Westmead, NSW, 2145, Australia.

Michel C Tchan (MC)

Department of Genetic Medicine, Westmead Hospital, Westmead, NSW, 2145, Australia; Sydney Medical School, University of Sydney, Camperdown, NSW, 2050, Australia.

Stuart M Grieve (SM)

Imaging and Phenotyping Laboratory, Charles Perkins Centre, Faculty of Medicine and Health, University of Sydney, NSW, 2006, Australia; Department of Radiology, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW, 2050, Australia. Electronic address: stuart.grieve@sydney.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH